leadf
logo-loader
viewCardieX Ltd

CardieX raises $3.207 million in share purchase plan, 220% above target

Funds raised will be used primarily for working capital purposes and investment into the expansion of product and market development initiatives.

Cardiex Ltd - Cardiex completes share purchase plan to raise $3.207 million
The allotment and issue of shares is expected to occur on Tuesday, January 12, 2021

CardieX Ltd (ASX:CDX) has completed its share purchase plan (SPP), receiving applications for fully paid ordinary shares from eligible shareholders at an issue price of $0.05 per share in the amount of $3.207 million.

This represents a 220% over-subscription over the target raise of $1 million.

The funds raised under the SPP will be used primarily for working capital purposes and investment into the expansion of product and market development initiatives.

“Shareholder confidence”

CardieX CEO and managing director Craig Cooper said: “We are very pleased with the support we have received under the SPP which is representative of the confidence that shareholders have in our growth plan and vision for the company.

“This is the most that the company has ever raised under an SPP at a time when innovation and leadership in healthcare and med-tech solutions are required more than ever.

“2021 will be a defining year for us with multiple new products and digital solutions on track for launch during the period.”

SPP details

In response to the strong demand from shareholders, the company has elected to accept the full $3.207 million of valid applications and not conduct any scale-back.

The allotment and issue of the SPP shares is expected to occur on Tuesday, January 12, 2021.

Quick facts: CardieX Ltd

Price: 0.082 AUD

ASX:CDX
Market: ASX
Market Cap: $75.8 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of CardieX Ltd named herein, including the promotion by the Company of CardieX Ltd in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

CardieX Limited signs disruptive deal with Chinese medical device company Andon

CardieX Limited (ASX: CDX) CEO Craig Cooper joined Steve Darling from Proactive with news the company has entered a co-development and commercial partnership agreement with Andon. Andon is one of China’s largest manufacturers of home-use medical electronic devices. Cooper talks about the deal...

on 9/9/20

2 min read